Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Studies report on developmental, adult neurogenesis

July 7, 2021

Vanderbilt University patents muscarinic M4 receptor antagonists

July 7, 2021

BNC-210 advances into phase IIb trial in PTSD

July 6, 2021

PTC Therapeutics discloses compounds for familial dysautonomia

July 6, 2021

Novel tau tubulin kinase 1 inhibitors reduce tau phosphorylation in vivo

July 6, 2021

Sperogenix to develop Abbisko's ABSK-021 for rare neurological diseases in China

July 5, 2021

Phase II trial evaluates bepranemab in mild cognitive impairment or mild Alzheimer's disease

July 2, 2021

Neurocrine Biosciences presents new muscarinic M4 receptor antagonists

July 2, 2021

Excitability phenotype screen identifies several targets in human amyotrophic lateral sclerosis

July 2, 2021

ARO-DUX4 both prevents and reverses FSHD phenotype in mice

July 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...